2,674
Views
153
CrossRef citations to date
0
Altmetric
Review

Vaccine adjuvant uses of poly-IC and derivatives

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Peidi Yin, Huifeng Li, Chao Ke, Guangxu Cao, Xiaoqian Xin, Junjiao Hu, Xiangran Cai, Lingfeng Li, Xiaowen Liu & Bin Du. (2020) Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response. International Journal of Nanomedicine 15, pages 1499-1515.
Read now
Eita Sasaki, Isao Hamaguchi & Takuo Mizukami. (2020) Pharmacodynamic and safety considerations for influenza vaccine and adjuvant design. Expert Opinion on Drug Metabolism & Toxicology 16:11, pages 1051-1061.
Read now
Zoila A. Lopez-Bujanda, Matthew G. Chaimowitz, Todd D. Armstrong, Jeremy B. Foote, Leisha A. Emens & Charles G. Drake. (2020) Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen. OncoImmunology 9:1.
Read now
Indranil Sarkar, Ravendra Garg & Sylvia van Drunen Littel-van den Hurk. (2019) Selection of adjuvants for vaccines targeting specific pathogens. Expert Review of Vaccines 18:5, pages 505-521.
Read now

Articles from other publishers (149)

Melanie Rutkowski. 2024. Clinical Immuno-Oncology. Clinical Immuno-Oncology 61 90.e11 .
Rimsha Bhatta, Joonsu Han, Yusheng Liu, Yang Bo, David Lee, Jiadiao Zhou, Yueji Wang, Erik Russell Nelson, Qian Chen, Xiaojia Shelly Zhang, Wael Hassaneen & Hua Wang. (2023) Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines. Nature Communications 14:1.
Crossref
Jonaid Ahmad Malik, Gurpreet Kaur & Javed N. Agrewala. (2023) Revolutionizing medicine with toll-like receptors: A path to strengthening cellular immunity. International Journal of Biological Macromolecules 253, pages 127252.
Crossref
He-Chin Hsieh, Chung-Chu Chen, Pin-Han Chou, Wen-Chun Liu & Suh-Chin Wu. (2023) Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit. Antiviral Research 220, pages 105752.
Crossref
Praveen Bhoopathi, Amit Kumar, Anjan K Pradhan, Santanu Maji, Padmanabhan Mannangatti, Jolene J Windle, Mark A Subler, Dongyu Zhang, Vignesh Vudatha, Jose G Trevino, Esha Madan, Azeddine Atfi, Devanand Sarkar, Rajan Gogna, Swadesh K Das, Luni Emdad & Paul B Fisher. (2023) Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity. Journal for ImmunoTherapy of Cancer 11:11, pages e007624.
Crossref
Chunxi Wang, Amelia Karlsson, Thomas H. OguinIIIIII, Andrew N. Macintyre, Gregory D. Sempowski, Kevin R. McCarthy, Yifei Wang, M. Anthony Moody & Fan Yuan. (2023) Transient inhibition of lysosomal functions potentiates nucleic acid vaccines. Proceedings of the National Academy of Sciences 120:44.
Crossref
Alexander Lamoot, Sonia Jangra, Gabriel Laghlali, Prajakta Warang, Gagandeep Singh, Lauren A. Chang, Seok‐Chan Park, Gagandeep Singh, Kim De Swarte, Zifu Zhong, Benoit Louage, Emily De Lombaerde, Tingting Ye, Yong Chen, Sara Cuadrado‐Castano, Stefan Lienenklaus, Niek N. Sanders, Bart N. Lambrecht, Adolfo García‐Sastre, Michael Schotsaert & Bruno G. De Geest. (2023) Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity. Small.
Crossref
Luigi Buonaguro & Maria Tagliamonte. (2023) Peptide-based vaccine for cancer therapies. Frontiers in Immunology 14.
Crossref
Darren Chen Pei Wong, Zekun Xia, Nandi Shao, Ivan Yow, T. Thivakar, Jin Ye Yeo, Andres M. Salazar, Yih‐Cherng Liou, Boon Chuan Low & Jeak Ling Ding. (2023) Hiltonol, a dsRNA Mimic, Promotes NK Cell Anticancer Cytotoxicity Through TAZ Cytoplasmic Sequestration. Advanced Therapeutics 6:8.
Crossref
Martin Hufbauer, Stephanie Rattay, Christian Hagen, Alexander Quaas, Herbert Pfister, Gunther Hartmann, Christoph Coch & Baki Akgül. (2023) Poly(I:C) Treatment Prevents Skin Tumor Formation in the Preclinical HPV8 Transgenic Mouse Model. Journal of Investigative Dermatology 143:7, pages 1197-1207.e3.
Crossref
Fernanda Caroline Coirada, Edgar Ruz Fernandes, Lucas Rodrigues de Mello, Viviane Schuch, Gúbio Soares Campos, Carla Torres Braconi, Silvia Beatriz Boscardin & Daniela Santoro Rosa. (2023) Heterologous DNA Prime- Subunit Protein Boost with Chikungunya Virus E2 Induces Neutralizing Antibodies and Cellular-Mediated Immunity. International Journal of Molecular Sciences 24:13, pages 10517.
Crossref
Carly Butkowsky, Natalie Aldor & Sarah Poynter. (2023) Toll‑like receptor 3 ligands for breast cancer therapies (Review). Molecular and Clinical Oncology 19:2.
Crossref
Julia T. Castro, Rory Brito, Natalia S. Hojo-Souza, Bárbara Azevedo, Natalia Salazar, Camila P. Ferreira, Caroline Junqueira, Ana Paula Fernandes, Ronnie Vasconcellos, Jamille M. Cardoso, Rodrigo D. O. Aguiar-Soares, Paula M. A. Vieira, Cláudia M. Carneiro, Bruno Valiate, Cristiane Toledo, Andres M. Salazar, Otávia Caballero, Joseli Lannes-Vieira, Santuza R. Teixeira, Alexandre B. Reis & Ricardo T. Gazzinelli. (2023) ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease. npj Vaccines 8:1.
Crossref
Annalaura Brai, Federica Poggialini, Claudia Pasqualini, Claudia Immacolata Trivisani, Chiara Vagaggini & Elena Dreassi. (2023) Progress towards Adjuvant Development: Focus on Antiviral Therapy. International Journal of Molecular Sciences 24:11, pages 9225.
Crossref
Irina Naletova, Barbara Tomasello, Francesco Attanasio & Victor V. Pleshkan. (2023) Prospects for the Use of Metal-Based Nanoparticles as Adjuvants for Local Cancer Immunotherapy. Pharmaceutics 15:5, pages 1346.
Crossref
Eleonora Sosa Cuevas, Philippe Saas & Caroline Aspord. (2023) Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation. Cancers 15:8, pages 2206.
Crossref
Yunuo Zheng, Bo Jiang, Hongmei Guo, Zhonghai Zhang, Bo Chen, Zhengkui Zhang, Shaoyuan Wu & Jiaojiao Zhao. (2023) The combinational nano-immunotherapy of ferumoxytol and poly(I:C) inhibits melanoma via boosting anti-angiogenic immunity. Nanomedicine: Nanotechnology, Biology and Medicine 49, pages 102658.
Crossref
Liu Wang, Keisuke Yoshii, Naoya Murase, Hidetoshi Yamada, Yutaka Fukuda, Ikuo Hirono & Hidehiro Kondo. (2023) Type I interferon induced by polyinosinic-polycytidylic acid does not contribute to the efficacy of a formalin-killed cell vaccine against Edwardsiella piscicida in the Japanese flounder (Paralichthys olivaceus). Fish & Shellfish Immunology 135, pages 108680.
Crossref
Solène Besson, Emilie Boucher, David Laurin, Olivier Manches, Caroline Aspord, Dalil Hannani & Pascal Fender. (2023) Stimulation of the immune system by a tumor antigen-bearing adenovirus-inspired VLP allows control of melanoma growth. Molecular Therapy - Methods & Clinical Development 28, pages 76-89.
Crossref
Viet Tram Duong, Prashamsa Koirala, Sung-Po R. Chen, Michael J. Monteiro, Mariusz Skwarczynski & Istvan Toth. (2023) Multiepitope Subunit Peptide-Based Nanovaccine against Porcine Circovirus Type 2 (PCV2) Elicited High Antibody Titers in Vaccinated Mice. Molecules 28:5, pages 2248.
Crossref
Zhitao Qi, Yang Xu, Biao Dong, Xiangyu Pi, Qihuan Zhang, Dezhong Wang & Zisheng Wang. (2023) Molecular characterization, structural and expression analysis of twelve CXC chemokines and eight CXC chemokine receptors in largemouth bass (Micropterus salmoides). Developmental & Comparative Immunology, pages 104673.
Crossref
Martin Panigaj, Elizabeth Skelly, Damian Beasock, Ian Marriott, M. Brittany Johnson, Jacqueline Salotti & Kirill A. Afonin. (2023) Therapeutic immunomodulation by rationally designed nucleic acids and nucleic acid nanoparticles. Frontiers in Immunology 14.
Crossref
Olga N. Kaplina, Svetlana G. Gamaley, Olga S. Ivanova & Elena D. Danilenko. (2023) Double-stranded RNAs are promising adjuvants for enhancing immunogenicity of vaccines. Journal of microbiology, epidemiology and immunobiology 99:6, pages 661-668.
Crossref
Kee Woong Kwon, Tae Gun Kang, Ara LeeSeung Mo JinYong Taik LimSung Jae Shin & Sang-Jun Ha. (2023) Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection . Immune Network 23:2.
Crossref
Kaikai Zhao, Liyang Jiang, Youjiao Si, Shujie Zhou, Zhaoqin Huang & Xiangjiao Meng. (2022) TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism. Cancer Immunology, Immunotherapy 72:1, pages 193-209.
Crossref
Bingbing Sun, Min Li, Zhiying Yao, Ge Yu & Yubin Ma. 2023.
Irene Veneziani, Claudia Alicata, Lorenzo Moretta & Enrico Maggi. (2022) The Latest Approach of Immunotherapy with Endosomal TLR Agonists Improving NK Cell Function: An Overview. Biomedicines 11:1, pages 64.
Crossref
Rui Yang, Sihui Yu, Tianhan Xu, Jiawen Zhang & Sufang Wu. (2022) Emerging role of RNA sensors in tumor microenvironment and immunotherapy. Journal of Hematology & Oncology 15:1.
Crossref
Hye Won Kwak, So-Hee Hong, Hyo-Jung Park, Hyeong-Jun Park, Yoo-Jin Bang, Jae-Yong Kim, Yu-Sun Lee, Seo-Hyeon Bae, Hyunho Yoon & Jae-Hwan Nam. (2022) Adjuvant effect of IRES-based single-stranded RNA on melanoma immunotherapy. BMC Cancer 22:1.
Crossref
Juan F. Hernandez-Franco, Shaojun Xie, Jyothi Thimmapuram, Darryl Ragland & Harm HogenEsch. (2022) Mechanism of activation of porcine dendritic cells by an α-D-glucan nanoparticle adjuvant and a nanoparticle/poly(I:C) combination adjuvant. Frontiers in Immunology 13.
Crossref
Anle Xu, Fei Han, Yuan Zhang, Tao Zhou & Tianxiang Gao. (2022) Comparative Transcriptomic Analyses Revealed the Effects of Poly (I:C) on the Liver and Spleen of Argyrosomus japonicus. International Journal of Molecular Sciences 23:17, pages 9801.
Crossref
Kris Genelyn Dimasuay, Niccolette Schaunaman, Bruce Berg, Diana Cervantes, Elke Kruger, Frank L. Heppner, Deborah A. Ferrington & Hong Wei Chu. (2022) Airway epithelial immunoproteasome subunit LMP7 protects against rhinovirus infection. Scientific Reports 12:1.
Crossref
Kiva Brennan, Simon Craven, Maria Cheung, Daniel Kane, Eleanor Noone, Joseph O'Callaghan, Eleanor J Molloy, Patrick T Walsh, Fionnuala M McAuliffe & Sarah L Doyle. (2022) Cytosolic dsRNA improves neonatal innate immune responses to adjuvants in use in pediatric vaccines. Journal of Leukocyte Biology 112:3, pages 523-537.
Crossref
Julia T. Castro, Patrick Azevedo, Marcílio J. Fumagalli, Natalia S. Hojo-Souza, Natalia Salazar, Gregório G. Almeida, Livia I. Oliveira, Lídia Faustino, Lis R. Antonelli, Tomas G. Marçal, Marconi Augusto, Bruno Valiate, Alex Fiorini, Bruna Rattis, Simone G. Ramos, Mariela Piccin, Osvaldo Campos Nonato, Luciana Benevides, Rubens Magalhães, Bruno Cassaro, Gabriela Burle, Daniel Doro, Jorge Kalil, Edson Durigon, Andrés Salazar, Otávia Caballero, Helton Santiago, Alexandre Machado, João S. Silva, Flávio da Fonseca, Ana Paula Fernandes, Santuza R. Teixeira & Ricardo T. Gazzinelli. (2022) Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein. Nature Communications 13:1.
Crossref
Neftali Ortega Alarcon, Maddy Jaramillo, Heidi M. Mansour & Bo Sun. (2022) Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms. Pharmaceutics 14:7, pages 1448.
Crossref
Júlio Souza dos-Santos, Luan Firmino-Cruz, Alessandra Marcia da Fonseca-Martins, Diogo Oliveira-Maciel, Gustavo Guadagnini Perez, Victor A. Roncaglia-Pereira, Carlos H. Dumard, Francisca H. Guedes-da-Silva, Ana C. Vicente Santos, Monique dos Santos Leandro, Jesuino Rafael Machado Ferreira, Kamila Guimarães-Pinto, Luciana Conde, Danielle A. S. Rodrigues, Marcus Vinicius de Mattos Silva, Renata G. F. Alvim, Tulio M. Lima, Federico F. Marsili, Daniel P. B. Abreu, Orlando C. Ferreira Jr.Ronaldo da Silva Mohana Borges, Amilcar Tanuri, Thiago Moreno L. Souza, Bartira Rossi-Bergmann, André M. Vale, Jerson Lima Silva, Andréa Cheble de Oliveira, Alessandra D’Almeida Filardy, Andre M. O. Gomes & Herbert Leonel de Matos Guedes. (2022) Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum. Frontiers in Immunology 13.
Crossref
Nicolas Çuburu, Lukasz Bialkowski, Sergio M. Pontejo, Shiv K. Sethi, Alexander T. F. Bell, Rina Kim, Cynthia D. Thompson, Douglas R. Lowy & John T. Schiller. (2022) Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors. Proceedings of the National Academy of Sciences 119:26.
Crossref
Alessio Facciolà, Giuseppa Visalli, Antonio Laganà & Angela Di Pietro. (2022) An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Vaccines 10:5, pages 819.
Crossref
Ana Rafaela Teixeira, Begoña Pérez-Cabezas, David M. Costa, Mónica Sá, Sylvain Golba, Hélèna Sefiane-Djemaoune, Joana Ribeiro, Izumi Kaneko, Shiroh Iwanaga, Masao Yuda, Moriya Tsuji, Silvia Beatriz Boscardin, Rogerio Amino, Anabela Cordeiro-da-Silva & Joana Tavares. (2022) Immunization with CSP and a RIG-I Agonist is Effective in Inducing a Functional and Protective Humoral Response Against Plasmodium. Frontiers in Immunology 13.
Crossref
Rosmely Hernandez & Thomas R. Malek. (2022) Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity. Frontiers in Oncology 12.
Crossref
María José Germanó, Juan Pablo Mackern-Oberti, Jessica Gardone Vitório, Mariana Costa Duarte, Daniel Carvalho Pimenta, Maria Victoria Sanchez, Flavia Alejandra Bruna, Esteban Sebastián Lozano, Ana Paula Fernandes & Diego Esteban Cargnelutti. (2022) Identification of Immunodominant Antigens From a First-Generation Vaccine Against Cutaneous Leishmaniasis. Frontiers in Immunology 13.
Crossref
Jean-Eudes Fahrner, Imran Lahmar, Anne-Gaëlle Goubet, Yacine Haddad, Agathe Carrier, Marine Mazzenga, Damien Drubay, Carolina Alves Costa Silva, Eric de Sousa, Cassandra Thelemaque, Cléa Melenotte, Agathe Dubuisson, Arthur Geraud, Gladys Ferrere, Roxanne Birebent, Camille Bigenwald, Marion Picard, Luigi Cerbone, Joana R. Lérias, Ariane Laparra, Alice Bernard-Tessier, Benoît Kloeckner, Marianne Gazzano, François-Xavier Danlos, Safae Terrisse, Eugenie Pizzato, Caroline Flament, Pierre Ly, Eric Tartour, Nadine Benhamouda, Lydia Meziani, Abdelhakim Ahmed-Belkacem, Makoto Miyara, Guy Gorochov, Fabrice Barlesi, Alexandre Trubert, Benjamin Ungar, Yeriel Estrada, Caroline Pradon, Emmanuelle Gallois, Fanny Pommeret, Emeline Colomba, Pernelle Lavaud, Marc Deloger, Nathalie Droin, Eric Deutsch, Bertrand Gachot, Jean-Philippe Spano, Mansouria Merad, Florian Scotté, Aurélien Marabelle, Frank Griscelli, Jean-Yves Blay, Jean-Charles Soria, Miriam Merad, Fabrice André, Juliette Villemonteix, Mathieu F. Chevalier, Sophie Caillat-Zucman, Florence Fenollar, Emma Guttman-Yassky, Odile Launay, Guido Kroemer, Bernard La Scola, Markus Maeurer, Lisa Derosa & Laurence Zitvogel. (2022) The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals. Cancer Discovery 12:4, pages 958-983.
Crossref
Yang Xu, Zhitao Qi, Qihuan Zhang, Jie Li, Shengyuan Zhang & Zisheng Wang. (2022) Molecular characterization and expression analysis of three interleukins (IL‐1β, IL‐15 and IL‐16) in largemouth bass ( Micropterus salmoides ) . Journal of Applied Ichthyology 38:2, pages 194-203.
Crossref
Sang-Hyun Kim, Ji-Hyun Park, Sun-Jae Lee, Hee-Sung Lee, Jae-Kyung Jung, Young-Ran Lee, Hyun-Il Cho, Jeong-Ki Kim, Kyungjae Kim, Chan-Su Park & Chong-Kil Lee. (2022) Efficient Anti-Tumor Immunotherapy Using Tumor Epitope-Coated Biodegradable Nanoparticles Combined With Polyinosinic-Polycytidylic Acid and an Anti-PD1 Monoclonal Antibody. Immune Network 22:5.
Crossref
Zohre Sadeghi, Mahdi Fasihi-Ramandi & Saeid Bouzari. (2022) Brucella antigens (BhuA, 7α-HSDH, FliC) in poly I:C adjuvant as potential vaccine candidates against brucellosis. Journal of Immunological Methods 500, pages 113172.
Crossref
Yichao Lu, Yingying Shi & Jian You. (2022) Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy. Journal of Controlled Release 341, pages 184-205.
Crossref
Anita Milicic, Sören Reinke, Joannah Fergusson, Erik B. Lindblad, Aneesh Thakur, George Corby, Stephanie Longet, Sabina Górska, Agnieszka Razim, Kefei Hu, Bror Morein, Marina Luchner, Dennis Christensen, Slavcho Mrenoshki, Sebnem Ercelen Ceylan, Sveinbjorn Gizurarson & Malachy Chigozie Ugwu. 2022. Vaccinology and Methods in Vaccine Research. Vaccinology and Methods in Vaccine Research 223 280 .
Bassel Akache, Felicity C. Stark, Gerard Agbayani, Tyler M. Renner & Michael J. McCluskie. 2022. Vaccine Design. Vaccine Design 179 231 .
Shengbo Zhang, Michaël Chopin & Stephen L. Nutt. (2021) Type 1 conventional dendritic cells: ontogeny, function, and emerging roles in cancer immunotherapy. Trends in Immunology 42:12, pages 1113-1127.
Crossref
Adriana Magalhães Santos Andresen & Tor Gjøen. (2021) Chitosan nanoparticle formulation attenuates poly (I:C) induced innate immune responses against inactivated virus vaccine in Atlantic salmon (Salmo salar). Comparative Biochemistry and Physiology Part D: Genomics and Proteomics 40, pages 100915.
Crossref
Cheng Zhong, Lixiang Wang, Shengzhao Hu, Chunliu Huang, Zijin Xia, Jing Liao, Wei Yi & Jun Chen. (2021) Poly(I:C) enhances the efficacy of phagocytosis checkpoint blockade immunotherapy by inducing IL-6 production. Journal of Leukocyte Biology 110:6, pages 1197-1208.
Crossref
Arturo Orlacchio & Pellegrino Mazzone. (2021) The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology. International Journal of Molecular Sciences 22:23, pages 12743.
Crossref
Takeshi Ishikawa, Shinichi Kageyama, Yoshihiro Miyahara, Tetsuya Okayama, Satoshi Kokura, Linan Wang, Eiichi Sato, Hideo Yagita, Yoshito Itoh & Hiroshi Shiku. (2021) Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients. Cancer Immunology, Immunotherapy 70:11, pages 3081-3091.
Crossref
Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki & Taro Kawai. (2021) Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants. Frontiers in Cellular and Infection Microbiology 11.
Crossref
F. Linzee Mabrey, Eric D Morrell & Mark M Wurfel. (2021) TLRs in COVID-19: How they drive immunopathology and the rationale for modulation. Innate Immunity 27:7-8, pages 503-513.
Crossref
Khiyam Hussain, Mark S. Cragg & Stephen A. Beers. (2021) Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody Immunotherapies. Cancers 13:19, pages 4904.
Crossref
Katherine M. Audsley, Teagan Wagner, Clara Ta, Hannah V. Newnes, Anthony C. Buzzai, Samantha A. Barnes, Ben Wylie, Jesse Armitage, Tsuneyasu Kaisho, Anthony Bosco, Alison McDonnell, Mark Cruickshank, Vanessa S. Fear, Bree Foley & Jason Waithman. (2021) IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies. Frontiers in Immunology 12.
Crossref
Asma Komal, Mamoona Noreen & Attalla F. El-Kott. (2021) TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review. Immunologic Research 69:4, pages 312-322.
Crossref
Ahmed Salah, Hao Wang, Yanqin Li, Meng Ji, Wen-Bin Ou, Nianmin Qi & Yuehong Wu. (2021) Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications. Frontiers in Cell and Developmental Biology 9.
Crossref
Yu Yan, Dan Yao & Xiaoyu Li. (2021) Immunological Mechanism and Clinical Application of PAMP Adjuvants. Recent Patents on Anti-Cancer Drug Discovery 16:1, pages 30-43.
Crossref
Ban Qi Tay, Quentin Wright, Rahul Ladwa, Christopher Perry, Graham Leggatt, Fiona Simpson, James W. Wells, Benedict J. Panizza, Ian H. Frazer & Jazmina L. G. Cruz. (2021) Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions. Vaccines 9:5, pages 535.
Crossref
Alessandra Rinah Nogueira Voges, Rodrigo Ubukata, Karina Velloso Braga Yazbek, Otávia Luisa Caballero, Andres Mario Salazar, Cristina de Oliveira Massoco & Maria Lucia Zaidan Dagli. (2021) Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events. Cancers 13:9, pages 2237.
Crossref
Saed Abbasi & Satoshi Uchida. (2021) Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines. Pharmaceutics 13:5, pages 644.
Crossref
Chenyang Yu, Caihua Zhang, Zhihui Kuang & Qiang Zheng. (2020) The Role of NLRP3 Inflammasome Activities in Bone Diseases and Vascular Calcification. Inflammation 44:2, pages 434-449.
Crossref
Marie Tamagne, Sadaf Pakdaman, Pablo Bartolucci, Anoosha Habibi, Frédéric Galactéros, France Pirenne & Benoît Vingert. (2021) Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patients. Blood Advances 5:5, pages 1278-1282.
Crossref
Elizabeth S. Levy, Ryan Chang, Colin R. Zamecnik, Miqdad O. Dhariwala, Lawrence Fong & Tejal A. Desai. (2021) Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor Immunity. Molecular Pharmaceutics 18:3, pages 1014-1025.
Crossref
Soheila Molaei, Masoomeh Dadkhah, Vahid Asghariazar, Chiman Karami & Elham Safarzadeh. (2021) The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies. International Immunopharmacology 92, pages 107051.
Crossref
Allison M. Owen, Jessica B. Fults, Naeem K. Patil, Antonio Hernandez & Julia K. Bohannon. (2021) TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection. Frontiers in Immunology 11.
Crossref
Valeria Lucarini, Ombretta Melaiu, Patrizia Tempora, Silvia D’Amico, Franco Locatelli & Doriana Fruci. (2021) Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment. Cancers 13:3, pages 433.
Crossref
Marina Luchner, Sören Reinke & Anita Milicic. (2021) TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases. Pharmaceutics 13:2, pages 142.
Crossref
Jessamine E. Hazlewood, Troy Dumenil, Thuy T. Le, Andrii Slonchak, Stephen H. Kazakoff, Ann-Marie Patch, Lesley-Ann Gray, Paul M. Howley, Liang Liu, John D. Hayball, Kexin Yan, Daniel J. Rawle, Natalie A. Prow & Andreas Suhrbier. (2021) Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures. PLOS Pathogens 17:1, pages e1009215.
Crossref
Marcelo Pires Amaral, Fernanda Caroline Coirada, Juliana de Souza Apostolico, Nádia Tomita, Edgar Ruz Fernandes, Higo Fernando Santos Souza, Rosa Maria Chura-Chambi, Ligia Morganti, Silvia Beatriz Boscardin & Daniela Santoro Rosa. (2021) Prime-boost with Chikungunya virus E2 envelope protein combined with Poly (I:C) induces specific humoral and cellular immune responses. Current Research in Immunology 2, pages 23-31.
Crossref
Ali Keshavarz, Atieh Pourbagheri‐Sigaroodi, Parisa Zafari, Nader Bagheri, Seyed H. Ghaffari & Davood Bashash. (2020) Toll‐like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonists. IUBMB Life 73:1, pages 10-25.
Crossref
Angela Mauriello, Carmen Manolio, Beatrice Cavalluzzo, Antonio Avallone, Marco Borrelli, Alessandro Morabito, Emanuele Iovine, Angela Chambery, Rosita Russo, Maria Lina Tornesello, Franco M. Buonaguro, Maria Tagliamonte & Luigi Buonaguro. (2020) Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy. Journal of Translational Medicine 18:1.
Crossref
Davinder Kaur, Latifa Chachi, Edith Gomez, Nicolas Sylvius, Shailendra R. Singh, Mohammadali Y. Ramsheh, Ruth Saunders & Christopher E. Brightling. (2020) ST2 expression and release by the bronchial epithelium is downregulated in asthma. Allergy 75:12, pages 3184-3194.
Crossref
Youngsub Lee, Woo H. Kim & Hyun S. Lillehoj. (2020) Development of antigen sandwich ELISA to detect interferon-alpha (IFN-α) using monoclonal antibodies in chicken. Veterinary Immunology and Immunopathology 229, pages 110124.
Crossref
Andres M. Salazar & Esteban Celis. (2020) Double-Stranded RNA Immunomodulators in Prostate Cancer. Urologic Clinics of North America 47:4, pages e1-e8.
Crossref
Dimple Chakravarty, Li Huang, Matthew Kahn & Ashutosh K. Tewari. (2020) Immunotherapy for Metastatic Prostate Cancer: Current and Emerging Treatment Options. Urologic Clinics of North America 47:4, pages 487-510.
Crossref
Iván Márquez-Rodas, Federico Longo, Maria E. Rodriguez-Ruiz, Antonio Calles, Santiago Ponce, Maria JoveBelén Rubio-Viqueira, Jose Luis Perez-GraciaAna Gómez-Rueda, Sara López-Tarruella, Mariano Ponz-Sarvise, Rosa ÁlvarezAinara Soria-RivasEnrique de Miguel, Rocío Ramos-Medina, Eduardo CastañonPablo Gajate, Cayetano Sempere-Ortega, Elisabeth Jiménez-AguilarM. Angela Aznar, Aitana CalvoPedro P. Lopez-Casas, Salvador Martín-AlgarraMiguel MartínDominique TersagoMarisol Quintero & Ignacio Melero. (2020) Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors. Science Translational Medicine 12:565.
Crossref
Sören Reinke, Aneesh Thakur, Cillian Gartlan, Jelena S. Bezbradica & Anita Milicic. (2020) Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants. Vaccines 8:3, pages 554.
Crossref
Beatris Mastelic-Gavillet, Apostolos Sarivalasis, Leyder Elena Lozano, Tania Wyss, Susana Inoges, Ingrid Jolanda Monique de Vries, Florence Dartiguenave, Patrice Jichlinski, Laurent Derrè, George Coukos, Ignacio Melero, Alexandre Harari, Pedro Romero, Selena Viganó & Lana Elias Kandalaft. (2020) Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer. European Journal of Cancer 135, pages 173-182.
Crossref
Daniel E. Speiser & Martin F. Bachmann. (2020) COVID-19: Mechanisms of Vaccination and Immunity. Vaccines 8:3, pages 404.
Crossref
Alexandra N. Tsoras, Kong M. Wong, Anant K. Paravastu & Julie A. Champion. (2020) Rational Design of Antigen Incorporation Into Subunit Vaccine Biomaterials Can Enhance Antigen-Specific Immune Responses. Frontiers in Immunology 11.
Crossref
Hyo‐Jung Park, Eun‐Kyoung Bang, Jung Joo Hong, Sang‐Myeong Lee, Hae Li Ko, Hye Won Kwak, Hyelim Park, Kyung Won Kang, Rhoon‐Ho Kim, Seung Rok Ryu, Green Kim, Hanseul Oh, Hye‐Jung Kim, Kyuri Lee, Minjeong Kim, Soo Young Kim, Jae‐Ouk Kim, Karim El‐Baz, Hyukjin Lee, Manki Song, Dae Gwin Jeong, Gyochang Keum & Jae‐Hwan Nam. (2020) Nanoformulated Single‐Stranded RNA‐Based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer: Inducing Humoral Immune Response by Activation of Antigen‐Presenting Cells. Angewandte Chemie International Edition 59:28, pages 11540-11549.
Crossref
Hyo‐Jung Park, Eun‐Kyoung Bang, Jung Joo Hong, Sang‐Myeong Lee, Hae Li Ko, Hye Won Kwak, Hyelim Park, Kyung Won Kang, Rhoon‐Ho Kim, Seung Rok Ryu, Green Kim, Hanseul Oh, Hye‐Jung Kim, Kyuri Lee, Minjeong Kim, Soo Young Kim, Jae‐Ouk Kim, Karim El‐Baz, Hyukjin Lee, Manki Song, Dae Gwin Jeong, Gyochang Keum & Jae‐Hwan Nam. (2020) Nanoformulated Single‐Stranded RNA‐Based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer: Inducing Humoral Immune Response by Activation of Antigen‐Presenting Cells. Angewandte Chemie 132:28, pages 11637-11646.
Crossref
Sarah M. McWhirter & Caroline A. Jefferies. (2020) Nucleic Acid Sensors as Therapeutic Targets for Human Disease. Immunity 53:1, pages 78-97.
Crossref
Domenica Musumeci, Andriy Mokhir & Giovanni N. Roviello. (2020) Synthesis and nucleic acid binding evaluation of a thyminyl l-diaminobutanoic acid-based nucleopeptide. Bioorganic Chemistry 100, pages 103862.
Crossref
Ting-Hsuan Chen, Chung-Chu Chen, Ming-Hsi Huang, Chung-Hsiung Huang, Jia-Tsrong Jan & Suh-Chin Wu. (2020) Use of PELC/CpG Adjuvant for Intranasal Immunization with Recombinant Hemagglutinin to Develop H7N9 Mucosal Vaccine. Vaccines 8:2, pages 240.
Crossref
Tingting Shen, Yu Zhang, Shurong Zhou, Shuibin Lin, Xiao-Bing Zhang & Guizhi Zhu. (2020) Nucleic Acid Immunotherapeutics for Cancer. ACS Applied Bio Materials 3:5, pages 2838-2849.
Crossref
Lizdany Flórez-Álvarez, Lanie Ruiz-Perez, Natalia Taborda & Juan C Hernandez. (2020) Toll-like receptors as a therapeutic target in cancer, infections and inflammatory diseases. Immunotherapy 12:5, pages 311-322.
Crossref
Marcelo Pires Amaral, Juliana de Souza Apostolico, Nádia Tomita, Fernanda Caroline Coirada, Victória Alves Santos Lunardelli, Edgar Ruz Fernandes, Higo Fernando Santos Souza, Renato Mancini Astray, Silvia Beatriz Boscardin & Daniela Santoro Rosa. (2020) Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses. Vaccine 38:20, pages 3653-3664.
Crossref
Zhi-Biao Wang & Jing Xu. (2020) Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant–Antigen Codelivery. Vaccines 8:1, pages 128.
Crossref
Katherine M. Audsley, Alison M. McDonnell & Jason Waithman. (2020) Cross-Presenting XCR1+ Dendritic Cells as Targets for Cancer Immunotherapy. Cells 9:3, pages 565.
Crossref
María José Germanó, Esteban Sebastián Lozano, María Victoria Sanchez, Flavia Alejandra Bruna, María Fernanda García-Bustos, Arianna Lourdes Sosa Lochedino, María Cristina Salomón, Ana Paula Fernandes, Juan Pablo Mackern-Oberti & Diego Esteban Cargnelutti. (2020) Evaluation of different total Leishmania amazonensis antigens for the development of a first-generation vaccine formulated with a Toll-like receptor-3 agonist to prevent cutaneous leishmaniasis. Memórias do Instituto Oswaldo Cruz 115.
Crossref
Hans-Uwe Simon, Alexander V. Karaulov & Martin F. Bachmann. (2020) Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection. International Archives of Allergy and Immunology 181:8, pages 624-628.
Crossref
Stefanie K. Wculek, Francisco J. Cueto, Adriana M. Mujal, Ignacio Melero, Matthew F. Krummel & David Sancho. (2019) Dendritic cells in cancer immunology and immunotherapy. Nature Reviews Immunology 20:1, pages 7-24.
Crossref
Seo Young Kwak, Seonmin Lee, Hee Dong Han, Suhwan Chang, Kyu-pyo Kim & Hyung Jun Ahn. (2019) PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor Growth. Molecular Pharmaceutics 16:12, pages 4940-4953.
Crossref
M. Angela Aznar, Lourdes Planelles, Mercedes Perez-Olivares, Carmen Molina, Saray Garasa, Iñaki Etxeberría, Guiomar Perez, Inmaculada Rodriguez, Elixabet Bolaños, Pedro Lopez-Casas, Maria E. Rodriguez-Ruiz, Jose L. Perez-Gracia, Ivan Marquez-Rodas, Alvaro Teijeira, Marisol Quintero & Ignacio Melero. (2019) Immunotherapeutic effects of intratumoral nanoplexed poly I:C. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Mark Aleynick, Judit Svensson-Arvelund, Christopher R. Flowers, Aurélien Marabelle & Joshua D. Brody. (2019) Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection. Clinical Cancer Research 25:21, pages 6283-6294.
Crossref
Lisa Munakata, Yoshihiko Tanimoto, Akio Osa, Jie Meng, Yasunari Haseda, Yujiro Naito, Hirotomo Machiyama, Atsushi Kumanogoh, Daiki Omata, Kazuo Maruyama, Yasuo Yoshioka, Yoshiaki Okada, Shohei Koyama, Ryo Suzuki & Taiki Aoshi. (2019) Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice. Journal of Controlled Release 313, pages 106-119.
Crossref
Alice Comberlato, Kaltrina Paloja & Maartje M. C. Bastings. (2019) Nucleic acids presenting polymer nanomaterials as vaccine adjuvants. Journal of Materials Chemistry B 7:41, pages 6321-6346.
Crossref
Sudhir Agrawal & Ekambar R. Kandimalla. (2019) Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors. Immuno-Oncology Technology 3, pages 15-23.
Crossref
Zohre Sadeghi, Mahdi Fasihi-Ramandi & Saeid Bouzari. (2019) Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection. International Immunopharmacology 75, pages 105829.
Crossref
Hye Won Kwak, Hyo-Jung Park, Hae Li Ko, Hyelim Park, Min Ho Cha, Sang-Myeong Lee, Kyung Won Kang, Rhoon-Ho Kim, Seung Rok Ryu, Hye-Jung Kim, Jae-Ouk Kim, Manki Song, Hun Kim, Dae Gwin Jeong, Eui-Cheol Shin & Jae-Hwan Nam. (2019) Cricket paralysis virus internal ribosome entry site-derived RNA promotes conventional vaccine efficacy by enhancing a balanced Th1/Th2 response. Vaccine 37:36, pages 5191-5202.
Crossref
Paolo Giovanelli, Tito A. Sandoval & Juan R. Cubillos-Ruiz. (2019) Dendritic Cell Metabolism and Function in Tumors. Trends in Immunology 40:8, pages 699-718.
Crossref
Dace Pjanova, Laima Mandrika, Ramona Petrovska, Kristine Vaivode & Simona Donina. (2019) Comparison of the effects of bacteriophage-derived dsRNA and poly(I:C) on ex vivo cultivated peripheral blood mononuclear cells. Immunology Letters 212, pages 114-119.
Crossref
Reyhaneh Moradi‐Marjaneh, Seyed Mahdi Hassanian, Malihe Hasanzadeh, Majid Rezayi, Mona Maftouh, Mehrane Mehramiz, Gordon A. Ferns, Majid Khazaei & Amir Avan. (2019) Therapeutic potential of toll‐like receptors in treatment of gynecological cancers. IUBMB Life 71:5, pages 549-564.
Crossref
Juliana de Souza Apostólico, Victória Alves Santos Lunardelli, Marcio Massao Yamamoto, Edecio Cunha-Neto, Silvia Beatriz Boscardin & Daniela Santoro Rosa. (2019) Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope Vaccine. Frontiers in Immunology 10.
Crossref
Ben Wylie, Christophe Macri, Justine Mintern & Jason Waithman. (2019) Dendritic Cells and Cancer: From Biology to Therapeutic Intervention. Cancers 11:4, pages 521.
Crossref
Mansi Saxena, Rachel L. Sabado, Melissa La Mar, Hiroshi Mohri, Andres M. Salazar, Hanqing Dong, Joel Correa Da Rosa, Martin Markowitz, Nina Bhardwaj & Elizabeth Miller. (2019) Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial. Frontiers in Immunology 10.
Crossref
Beatriz Escudero-Pérez & César Muñoz-Fontela. (2019) Role of Type I Interferons on Filovirus Pathogenesis. Vaccines 7:1, pages 22.
Crossref
Sudhir Agrawal & Ekambar R. Kandimalla. 2019. Advances in Nucleic Acid Therapeutics. Advances in Nucleic Acid Therapeutics 306 338 .
Raymond M. Schiffelers, Erik Oude Blenke & Enrico Mastrobattista. 2019. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology 305 322 .
Guillaume B. E. Stewart-JonesGwo-Yu ChuangKai XuTongqing ZhouPriyamvada AcharyaYaroslav TsybovskyLi OuBaoshan ZhangBlanca Fernandez-RodriguezValentina GilardiChiara Silacci-FregniMartina BeltramelloUlrich BaxaAliaksandr DruzWing-Pui KongPaul V. ThomasYongping YangKathryn E. FouldsJohn-Paul ToddHui WeiAndres M. Salazar, Diana G. ScorpioBridget CarragherClinton S. PotterDavide Corti, John R. MascolaAntonio LanzavecchiaPeter D. Kwong. (2018) Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4. Proceedings of the National Academy of Sciences 115:48, pages 12265-12270.
Crossref
Eita Sasaki, Haruka Momose, Yuki Hiradate, Takuo Mizukami & Isao Hamaguchi. (2018) Establishment of a novel safety assessment method for vaccine adjuvant development. Vaccine 36:46, pages 7112-7118.
Crossref
Chrisann Kyi, Vladimir Roudko, Rachel Sabado, Yvonne Saenger, William Loging, John Mandeli, Tin Htwe Thin, Deborah Lehrer, Michael Donovan, Marshall Posner, Krzysztof Misiukiewicz, Benjamin Greenbaum, Andres Salazar, Philip Friedlander & Nina Bhardwaj. (2018) Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial. Clinical Cancer Research 24:20, pages 4937-4948.
Crossref
Gabriel Kristian Pedersen, Peter Andersen & Dennis Christensen. (2018) Immunocorrelates of CAF family adjuvants. Seminars in Immunology 39, pages 4-13.
Crossref
Marc J. Braunstein, John Kucharczyk & Sylvia Adams. (2018) Targeting Toll-Like Receptors for Cancer Therapy. Targeted Oncology 13:5, pages 583-598.
Crossref
Wei Shi, Yiming Kou, Jinghui Xiao, Lijuan Zhang, Feng Gao, Wei Kong, Weiheng Su, Chunlai Jiang & Yong Zhang. (2018) Comparison of immunogenicity, efficacy and transcriptome changes of inactivated rabies virus vaccine with different adjuvants. Vaccine 36:33, pages 5020-5029.
Crossref
Yusuke Sato, Satoru Motoyama, Akiyuki Wakita, Yuta Kawakita, Jiajia Liu, Yushi Nagaki, Hiroshi Nanjo, Kaori Terata, Kazuhiro Imai, Hajime Saito & Yoshihiro Minamiya. (2018) TLR3 expression status predicts prognosis in patients with advanced thoracic esophageal squamous cell carcinoma after esophagectomy. The American Journal of Surgery 216:2, pages 319-325.
Crossref
Kevin Brown, Montserrat Puig, Lydia Haile, Derek Ireland, John Martucci & Daniela Verthelyi. 2018. Oligonucleotide‐Based Drugs and Therapeutics. Oligonucleotide‐Based Drugs and Therapeutics 411 444 .
M.E. Rodríguez-Ruiz, J.L. Perez-Gracia, I. Rodríguez, C. Alfaro, C. Oñate, G. Pérez, I. Gil-Bazo, A. Benito, S. Inogés, A. López-Diaz de Cerio, M. Ponz-Sarvise, L. Resano, P. Berraondo, B. Barbés, S. Martin-Algarra, A. Gúrpide, M.F. Sanmamed, C. de Andrea, A.M. Salazar & I. Melero. (2018) Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients. Annals of Oncology 29:5, pages 1312-1319.
Crossref
Zhenghui Xu & Peter Michael Moyle. (2017) Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands. Bioconjugate Chemistry 29:3, pages 572-586.
Crossref
Timothy Green & Peter Speck. (2018) Antiviral Defense and Innate Immune Memory in the Oyster. Viruses 10:3, pages 133.
Crossref
Anmol Chandele. (2018) New Technologies for Vaccine Development: Harnessing the Power of Human Immunology. Journal of the Indian Institute of Science 98:1, pages 33-47.
Crossref
Jitka Mucksová, Jiří Plachý, Ondřej Staněk, Jiří Hejnar, Jiří Kalina, Barbora Benešová & Pavel Trefil. (2017) Cytokine response to the RSV antigen delivered by dendritic cell-directed vaccination in congenic chicken lines. Veterinary Research 48:1.
Crossref
Shikhar Mehrotra, Carolyn D. Britten, Steve Chin, Elizabeth Garrett-Mayer, Colleen A. Cloud, Mingli Li, Gina Scurti, Mohamed L. Salem, Michelle H. Nelson, Melanie B. Thomas, Chrystal M. Paulos, Andres M. Salazar, Michael I. Nishimura, Mark P. Rubinstein, Zihai Li & David J. Cole. (2017) Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. Journal of Hematology & Oncology 10:1.
Crossref
Martin T. Speth, Urska Repnik, Elisabeth Müller, Julia Spanier, Ulrich Kalinke, Alexandre Corthay & Gareth Griffiths. (2017) Poly(I:C)-Encapsulating Nanoparticles Enhance Innate Immune Responses to the Tuberculosis Vaccine Bacille Calmette–Guérin (BCG) via Synergistic Activation of Innate Immune Receptors. Molecular Pharmaceutics 14:11, pages 4098-4112.
Crossref
Kai Schulze, Thomas Ebensen, Lorne A. Babiuk, Volker Gerdts & Carlos A. Guzman. (2017) Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice. Nanomedicine: Nanotechnology, Biology and Medicine 13:7, pages 2169-2178.
Crossref
Mansi Saxena & Nina Bhardwaj. (2017) Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines. Current Opinion in Immunology 47, pages 35-43.
Crossref
Xiaowei Sun, Weili Yu, Quanhai Pang & Tao Hu. (2017) Conjugation Reaction with 8-Arm PEG Markedly Improves the Immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 Fusion Protein . Bioconjugate Chemistry 28:6, pages 1658-1668.
Crossref
Shuyun Dong, Tiefeng Xu, Peng Wang, Peng Zhao & Mingnan Chen. (2017) Engineering of a self-adjuvanted iTEP-delivered CTL vaccine. Acta Pharmacologica Sinica 38:6, pages 914-923.
Crossref
Denis Migliorini, Valérie Dutoit, Paul R. Walker & Pierre-Yves Dietrich. (2017) Immunothérapie des gliomes : illusion ou espoir ?. Bulletin du Cancer 104:5, pages 476-484.
Crossref
Léa Martelet, Sonia Lacouture, Guillaume Goyette-Desjardins, Guy Beauchamp, Charles Surprenant, Marcelo Gottschalk & Mariela Segura. (2017) Porcine Dendritic Cells as an In Vitro Model to Assess the Immunological Behaviour of Streptococcus suis Subunit Vaccine Formulations and the Polarizing Effect of Adjuvants. Pathogens 6:1, pages 13.
Crossref
Ji-Kun Li, Jesse J. Balic, Liang Yu & Brendan Jenkins. 2017. Regulation of Inflammatory Signaling in Health and Disease. Regulation of Inflammatory Signaling in Health and Disease 195 212 .
Hiep Khong & Willem W. Overwijk. (2016) Adjuvants for peptide-based cancer vaccines. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Martin Tobias Speth, Urska Repnik & Gareth Griffiths. (2016) Layer-by-layer nanocoating of live Bacille-Calmette-Guérin mycobacteria with poly(I:C) and chitosan enhances pro-inflammatory activation and bactericidal capacity in murine macrophages. Biomaterials 111, pages 1-12.
Crossref
Annina M. Hafner, Blaise Corthésy, Marcus Textor & Hans P. Merkle. (2016) Surface-assembled poly(I:C) on PEGylated PLGA microspheres as vaccine adjuvant: APC activation and bystander cell stimulation. International Journal of Pharmaceutics 514:1, pages 176-188.
Crossref
E. A. Chromova, E. A. Akhmatova, S. A. Skhodova, I. A. Semochkin, V. G. Khomenkov, N. K. Akhmatova & M. P. Kostinov. (2016) EFFECT OF INFLUENZA VACCINES ON SUBPOPULATIONS OF BLOOD DENDRITIC CELLS. Journal of microbiology, epidemiology and immunobiology 93:5, pages 23-28.
Crossref
Roy Rampling, Sharon Peoples, Paul J. Mulholland, Allan James, Omar Al-Salihi, Christopher J. Twelves, Catherine McBain, Sarah Jefferies, Alan Jackson, Willie Stewart, Juha Lindner, Sarah Kutscher, Norbert Hilf, Lesley McGuigan, Jane Peters, Karen Hill, Oliver Schoor, Harpreet Singh-Jasuja, Sarah E. Halford & James W.A. Ritchie. (2016) A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research 22:19, pages 4776-4785.
Crossref
Meropi Aravantinou, Ines Frank, Magnus Hallor, Rachel Singer, Hugo Tharinger, Jessica Kenney, Agegnehu Gettie, Brooke Grasperge, James Blanchard, Andres Salazar, Michael Piatak, Jeffrey D. Lifson, Melissa Robbiani & Nina Derby. (2016) PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo. PLOS ONE 11:9, pages e0161730.
Crossref
Emilie Bardel, Remi Doucet-Ladeveze, Cyrille Mathieu, Ali M Harandi, Bertrand Dubois & Dominique Kaiserlian. (2016) Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection. npj Vaccines 1:1.
Crossref
Tom Y.-H. Wu. (2016) Strategies for designing synthetic immune agonists. Immunology 148:4, pages 315-325.
Crossref
Bo Liu, Xia Wang, Tai-Zhong Chen, Guang-Liang Li, Chang-Chun Tan, Yong Chen & Shao-Qiang Duan. (2016) Polarization of M1 tumor associated macrophage promoted by the activation of TLR3 signal pathway. Asian Pacific Journal of Tropical Medicine 9:5, pages 484-488.
Crossref
Qingrui Huang, Weili Yu & Tao Hu. (2016) Potent Antigen-Adjuvant Delivery System by Conjugation of Mycobacterium tuberculosis Ag85B-HspX Fusion Protein with Arabinogalactan-Poly(I:C) Conjugate . Bioconjugate Chemistry 27:4, pages 1165-1174.
Crossref
Chandramohan Natarajan, Song-Yi Yao & Subramaniam Sriram. (2016) TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair. PLOS ONE 11:3, pages e0152163.
Crossref
Hye-Mi Park, Hyun-Il Cho, Chang-Ae Shin, Hyun-Jung Shon & Tai-Gyu Kim. (2016) Zoledronic acid induces dose-dependent increase of antigen-specific CD8 T-cell responses in combination with peptide/poly-IC vaccine. Vaccine 34:10, pages 1275-1281.
Crossref
Karen A.O. Martins, Christopher L. Cooper, Sabrina M. Stronsky, Sarah L.W. Norris, Steven A. Kwilas, Jesse T. Steffens, Jacqueline G. Benko, Sean A. van Tongeren & Sina Bavari. (2016) Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity. EBioMedicine 3, pages 67-78.
Crossref
Leonardo Rivadeneyra, Roberto Gabriel Pozner, Roberto Meiss, Carlos Fondevila, Ricardo Martin Gómez & Mirta Schattner. (2017) Poly (I:C) downregulates platelet production and function through type I interferon. Thrombosis and Haemostasis 114:11, pages 982-993.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.